Sana Biotechnology Inc Financial Flexibility Index
Sana Biotechnology Inc financial flexibility index. Sana Biotechnology Inc (SANA) has a Financial Flexibility Index of -0.11x as of June 2026. Free cash flow of $-31.17 Million (operating CF $-32.79 Million minus capex $1.62 Million) represents 0% of total liabilities ($276.95 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sana Biotechnology Inc (2018–2025)
Financial flexibility index of Sana Biotechnology Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Sana Biotechnology Inc across 8 annual periods. Check earnings quality score of Sana Biotechnology Inc to evaluate the quality of earnings relative to operating cash generation.
Sana Biotechnology Inc Financial Flexibility Index by Year (2018–2025)
Sana Biotechnology Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Sana Biotechnology Inc. For the full cash flow conversion analysis, see SANA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-142.89 Million | $-143.83 Million | $256.01 Million | ▲ +26.3% |
| 2024 | -0.76x | $-189.72 Million | $-223.15 Million | $250.52 Million | ▲ +9.9% |
| 2023 | -0.84x | $-233.55 Million | $-253.58 Million | $277.79 Million | ▼ -1.0% |
| 2022 | -0.83x | $-269.17 Million | $-290.05 Million | $323.40 Million | ▼ -50.9% |
| 2021 | -0.55x | $-221.19 Million | $-251.05 Million | $400.90 Million | ▼ -456.8% |
| 2020 | -0.10x | $-114.11 Million | $-137.98 Million | $1.15 Billion | ▲ +6.8% |
| 2019 | -0.11x | $-59.32 Million | $-85.50 Million | $557.73 Million | ▲ +61.2% |
| 2018 | -0.27x | $-13.04 Million | $-13.49 Million | $47.52 Million | — |